Resideo Technologies Q3 Earnings and Revenues Top Estimates
APDN Stock | USD 0.15 0.01 6.25% |
About 64% of Applied DNA's investor base is looking to short. The analysis of overall sentiment of trading Applied DNA Sciences stock suggests that many investors are alarmed at this time. Applied DNA's investing sentiment overview a quick insight into current market opportunities from investing in Applied DNA Sciences. Many technical investors use Applied DNA Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Applied |
Resideo Technologies delivered earnings and revenue surprises of 1.75 percent and 0.69, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
Applied DNA Fundamental Analysis
We analyze Applied DNA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied DNA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied DNA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Applied DNA is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Applied DNA Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Applied DNA stock to make a market-neutral strategy. Peer analysis of Applied DNA could also be used in its relative valuation, which is a method of valuing Applied DNA by comparing valuation metrics with similar companies.
Peers
Applied DNA Related Equities
BNR | Burning Rock | 16.01 | ||||
DRIO | DarioHealth Corp | 9.72 | ||||
STIM | Neuronetics | 4.17 | ||||
XGN | Exagen | 3.39 | ||||
SERA | Sera Prognostics | 1.81 | ||||
ISPC | ISpecimen | 1.69 | ||||
PRE | Prenetics Global | 1.13 | ||||
PSNL | Personalis | 1.02 | ||||
BDSX | Biodesix | 0.70 | ||||
FONR | Fonar | 0.49 | ||||
TRIB | Trinity Biotech | 1.79 | ||||
OCX | OncoCyte Corp | 3.56 | ||||
MYNZ | Mainz Biomed | 15.38 |
Check out Applied DNA Hype Analysis, Applied DNA Correlation and Applied DNA Performance. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.